281 related articles for article (PubMed ID: 33181138)
1. RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling.
Sarma A; Gajan A; Kim S; Gurdziel K; Mao G; Nangia-Makker P; Shekhar MPV
Am J Pathol; 2021 Feb; 191(2):368-384. PubMed ID: 33181138
[TBL] [Abstract][Full Text] [Related]
2. Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization.
Gajan A; Martin CE; Kim S; Joshi M; Michelhaugh SK; Sloma I; Mittal S; Firestine S; Shekhar MPV
Cells; 2019 Nov; 8(11):. PubMed ID: 31683936
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization.
Sanders MA; Brahemi G; Nangia-Makker P; Balan V; Morelli M; Kothayer H; Westwell AD; Shekhar MPV
Mol Cancer Ther; 2013 Apr; 12(4):373-83. PubMed ID: 23339190
[TBL] [Abstract][Full Text] [Related]
4. Rad6B acts downstream of Wnt signaling to stabilize β-catenin: Implications for a novel Wnt/β-catenin target.
Gerard B; Tait L; Nangia-Makker P; Shekhar MP
J Mol Signal; 2011 Jul; 6():6. PubMed ID: 21767405
[TBL] [Abstract][Full Text] [Related]
5. Rad6B is a positive regulator of beta-catenin stabilization.
Shekhar MP; Gerard B; Pauley RJ; Williams BO; Tait L
Cancer Res; 2008 Mar; 68(6):1741-50. PubMed ID: 18339854
[TBL] [Abstract][Full Text] [Related]
6. Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin.
Gerard B; Sanders MA; Visscher DW; Tait L; Shekhar MP
Biochim Biophys Acta; 2012 Oct; 1823(10):1686-96. PubMed ID: 22705350
[TBL] [Abstract][Full Text] [Related]
7. Essential role of T-cell factor/beta-catenin in regulation of Rad6B: a potential mechanism for Rad6B overexpression in breast cancer cells.
Shekhar MP; Tait L; Gerard B
Mol Cancer Res; 2006 Oct; 4(10):729-45. PubMed ID: 17050667
[TBL] [Abstract][Full Text] [Related]
8. 1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/β-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-M.
Kundu A; Khouri MG; Aryana S; Firestone GL
Carcinogenesis; 2017 Dec; 38(12):1207-1217. PubMed ID: 29028954
[TBL] [Abstract][Full Text] [Related]
9. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
Schepsky A; Bruser K; Gunnarsson GJ; Goodall J; Hallsson JH; Goding CR; Steingrimsson E; Hecht A
Mol Cell Biol; 2006 Dec; 26(23):8914-27. PubMed ID: 17000761
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin inhibits melanocyte migration but induces melanoma metastasis.
Gallagher SJ; Rambow F; Kumasaka M; Champeval D; Bellacosa A; Delmas V; Larue L
Oncogene; 2013 Apr; 32(17):2230-8. PubMed ID: 22665063
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
[TBL] [Abstract][Full Text] [Related]
12. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
[TBL] [Abstract][Full Text] [Related]
14. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
16. Rad6 is a Potential Early Marker of Melanoma Development.
Rosner K; Adsule S; Haynes B; Kirou E; Kato I; Mehregan DR; Shekhar MP
Transl Oncol; 2014 May; 7(3):384-92. PubMed ID: 24831578
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling inhibitor ICG-001 enhances pigmentation of cultured melanoma cells.
Kim KI; Jeong DS; Jung EC; Lee JH; Kim CD; Yoon TJ
J Dermatol Sci; 2016 Nov; 84(2):160-168. PubMed ID: 27567978
[TBL] [Abstract][Full Text] [Related]
18. The WNT/Beta-catenin pathway in melanoma.
Larue L; Delmas V
Front Biosci; 2006 Jan; 11():733-42. PubMed ID: 16146765
[TBL] [Abstract][Full Text] [Related]
19. Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma.
Prabhakar K; Rodrίguez CI; Jayanthy AS; Mikheil DM; Bhasker AI; Perera RJ; Setaluri V
Mol Carcinog; 2019 Nov; 58(11):1974-1984. PubMed ID: 31338875
[TBL] [Abstract][Full Text] [Related]
20. RAD6B overexpression confers chemoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response.
Lyakhovich A; Shekhar MP
Oncogene; 2004 Apr; 23(17):3097-106. PubMed ID: 14981545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
